Apontis Pharma AG (id:2859 APPH)
9.90 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/22/2024 7:37:20 AM)
Exchange closed, opens in 1 hour 22 minutes
1.85 EUR (1.85%)
1.64 EUR (1.64%)
46.88 EUR (46.88%)
13.79 EUR (13.79%)
159.84 EUR (159.84%)
-47.62 EUR (-47.62%)
About Apontis Pharma AG
Market Capitalization 82.79M
Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany.
| Headquarters (address) |
Alfred-Nobel-Str. 10 Monheim am Rhein 40789 Germany |
| Phone | 49 2173 8955 4949 |
| Website | https://apontis-pharma.de |
| Employees | 177 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | APPH |
| Exchange | Xetra Frankfurt Stock Exchange |
| Currency | EUR |
| 52 week range | 3.59 - 10.10 |
| Market Capitalization | 82.79M |
| P/E trailing | 17.88 |
| P/E forward | 21.17 |
| Price/Sale | 2.04 |
| Price/Book | 2.62 |
| Beta | 1.24 |
| EPS | -0.830 |
| EPS Germany (ID:66, base:322) | 2.36 |